RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Orthopaedic Research

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jor.20323PMID 17262820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases participate in osteosarcoma invasion.

  2005cited by this paper
• A systematic review of the influence of different titanium surfaces on proliferation, differentiation and protein synthesis of osteoblast-like MG63 cells.

  2004cited by this paper
• Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcomaFindings in 42 patients followed for 1–16 years

  2004cited by this paper
• Biology and therapeutic advances for pediatric osteosarcoma.

  2004influential reference
• Matrix metalloproteinase inhibitor reversion‐inducing cysteine‐rich protein with Kazal motifs

  2003cited by this paper
• RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

  2003cited by this paper
• RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling

  2003cited by this paper
• The molecular basis of skeletal metastases.

  2003cited by this paper
• Membrane-associated MMP regulators: novel cell adhesion tumor suppressor proteins?

  2002cited by this paper
• Real-Time Quantitative PCR

  2002cited by this paper
• Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.

  2002cited by this paper
• Matrix metalloproteinase inhibitors: current developments and future perspectives.

  2001cited by this paper
• RECK gene expression in hepatocellular carcinoma: Correlation with invasion‐related clinicopathological factors and its clinical significance

  2001cited by this paper
• Development of matrix metalloproteinase inhibitors in cancer therapy.

  2001cited by this paper
• The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

  2001cited by this paper
• Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms.

  1998cited by this paper
• Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

  1998influential reference
• Real time quantitative PCR.

  1996cited by this paper
• Stromal cell expression of components of matrix-degrading protease systems in human cancer.

  1996cited by this paper
• Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

  1993cited by this paper

• Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis

  2023cites this paper
• Importance of Metalloproteinase Enzyme Group in Selected Skeletal System Diseases

  2023influential citation
• Overexpression Pattern of miR-301b in Osteosarcoma and Its Relevance with Osteosarcoma Cellular Behaviors via Modulating SNX10

  2022cites this paper
• RECK Variants are Associated with Clinicopathological Features and Decreased Susceptibility in Mexican Patients with Colorectal Cancer.

  2022cites this paper
• Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms.

  2021cites this paper
• The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH

  2021cites this paper
• The role of miR-21/RECK in the inhibition of osteosarcoma by curcumin.

  2020cites this paper
• Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases

  2020cites this paper
• Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway

  2019cites this paper
• Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy.

  2019cites this paper
• Naa10p promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas

  2018cites this paper
• N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas.

  2018cites this paper
• Bedeutung des reversion-inducing cysteine-rich protein with Kazal motifs (RECK) für Wachstum, Beweglichkeit und Differenzierung humaner mesenchymaler Stammzellen

  2017cites this paper
• MicroRNA-155 targets MAP3K10 and regulates osteosarcoma cell growth.

  2017cites this paper
• Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity.

  2017cites this paper
• Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma

  2016cites this paper
• Bone microenvironment signals in osteosarcoma development

  2015cites this paper
• MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics

  2015cites this paper
• Retraction Note: Establishing an osteosarcoma associated protein-protein interaction network to explore the pathogenesis of osteosarcoma

  2015cites this paper
• Reduced Expression of RECK Protein May Help Differentiate Cutaneous Malignant Melanoma from Melanocytic Nevus.

  2015cites this paper
• RECK Gene Polymorphism is Associated with Susceptibility and Prognosis of Wilms’ Tumor in Chinese Children

  2015cites this paper
• Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma

  2015cites this paper
• New Medical/Biologic Paradigms in the Treatment of Bone Tumors

  2014cites this paper
• Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis

  2014cites this paper
• Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas

  2014cites this paper
• Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.

  2013influential citation
• Establishing an osteosarcoma associated protein-protein interaction network to explore the pathogenesis of osteosarcoma

  2013cites this paper
• The miRNAs in the pathgenesis of osteosarcoma.

  2013cites this paper
• Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms

  2012cites this paper
• Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities

  2012cites this paper
• Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus

  2012cites this paper
• The metalloproteinase inhibitor Reck is essential for zebrafish DRG development

  2012cites this paper
• RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).

  2012cites this paper
• MicroRNA Gene Regulatory Networks in Peripheral Nerve Sheath Tumors

  2012cites this paper
• MicroRNA Involvement in Osteosarcoma

  2012cites this paper
• MicroRNA-mediated gene regulations in human sarcomas

  2012cites this paper
• The Molecular Basis of Sarcoma

  2011cites this paper
• RECK in osteosarcoma

  2011cites this paper
• Current concepts on pathogenesis and biology of metastatic osteosarcoma tumors.

  2011cites this paper
• Identification de marqueurs de pronostic impliqués dans l'angiogenèse et régulés par un mécanisme épigénétique dans le cancer du sein

  2011cites this paper
• Identification of Hammerhead Ribozymes in All Domains of Life Reveals Novel Structural Variations

  2011cites this paper
• The Molecular Pathogenesis of Osteosarcoma: A Review

  2011cites this paper
• MicroRNA-21 is involved in osteosarcoma cell invasion and migration

  2011cites this paper
• Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma

  2010cites this paper
• Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas

  2010cites this paper
• Caracterização do perfil de expressão de MMPs e de seus inibidores, TIMPs e Reck, em linhagens representativas dos diferentes estágios de progressão do melanona humano

  2010cites this paper
• Lentivirus-mediated reversion-inducing cysteine-rich protein with Kazal motifs gene transfer suppresses pancreatic cancer invasion in vitro.

  2010cites this paper
• Matrix Metalloproteinases 2, 7, 9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in the Sera of Patients with Bone Tumors

  2010cites this paper
• Expression of RECK gene in the osteosarcoma cell line and its correlation with MMP-2

  2009cites this paper
• Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma

  2009cites this paper
• Expression of RECK and matrix metalloproteinase-2 in ameloblastoma

  2009cites this paper
• Biomarkers in Osteosarcoma.

  2009cites this paper
• Osteosarcoma treatment: state of the art

  2009influential citation
• A review of clinical and molecular prognostic factors in osteosarcoma

  2008influential citation
• Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK)

  2008cites this paper
• The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo

  2008cites this paper
• Recklessness as a hallmark of aggressive cancer

  2007cites this paper
• RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer

  2007cites this paper